New patent expiration for Leo Labs drug PICATO

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for PICATO
Annual Drug Patent Expirations for PICATO

Picato is a drug marketed by Leo Labs and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug and one Paragraph IV challenge.

PICATO drug price trends.

Drug patent litigation for PICATO.

This drug has forty-eight patent family members in twenty-five countries.

The generic ingredient in PICATO is ingenol mebutate. One supplier is listed for this compound. Additional details are available on the ingenol mebutate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top